Rock Creek Pharmaceuticals (RCPI) Return on Assets ROA from the second quarter of 2016 to second quarter of 2015 and for the year 2016, Average High and Low, Fundamental Ratios from Jun 30 2016 to Jun 30 2015 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rock Creek Pharmaceuticals, Inc.  (RCPI)


Rock Creek Pharmaceuticals's ROA from the second quarter of 2016 to the second quarter of 2015 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Rock Creek Pharmaceuticals's ROA in the second quarter of 2016?
Rock Creek Pharmaceuticals, Inc. recorded a cumulative net loss of $-11 million during 12 months ending in the second quarter of 2016, resulting in a negative return on assets (ROA) of -94.22%.

However, within the Healthcare sector 549 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2016 quarter, so far to 4779, from total ROA ranking in the first quarter of 2016 at 4799.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2016)
II. Quarter		 (Mar 31 2016)
I. Quarter		 (Dec 31 2015)
IV. Quarter		 (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter
Y / Y Total Assets Change 183.13 % 157 % 119.21 % -59.81 % -55.82 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -11 -9 -7 -13 -20
Return On Assets (TTM) -94.22 % -92.64 % -87.82 % -252.02 % -341.84 %
RCPI's Total Ranking # 4779 # 4799 # 5004 # 5271 # 5436
Total Assets (TTM) in million 12 14 20 2 4
Seq. Total Assets Change -15.74 % -28.49 % 861.49 % -51.13 % -23.52 %
Seq. Net Income Change - - - - -

RCPI's 5 Years Annual ROA >> Back to RCPI Management Effectiveness >> Compare RCPI ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 259
Sector # 550
Overall # 4044

Return On Assets Statistics
High Average Low
-87.82 %
-225.43 %
-438.01 %
(Dec 31 2015)   (Mar 31 2015)





Financial Statements
Rock Creek Pharmaceuticals's Assets $ 12 million RCPI's Balance sheet
Rock Creek Pharmaceuticals's Income $ -3 million Quarterly RCPI's Income Statement
RCPI's Income by Division See RCPI's Income by Division



Annual Return On Assets (Dec 31 2015)
FY 2015		 (Dec 31 2014)
FY 2014		 (Dec 31 2011)
FY 2011
FY
FY
Y / Y Total Assets Change 119.21 % -47.78 % - - -
Total Assets in million 20 9 17 0 0
Y / Y Net Income Change - - - - -
Net Income in million -7 -39 -38 0 0
Annual Return On Assets -35.02 % -431.95 % -222.45 % - -

RCPI's 5 Years Annual ROA >> Back to RCPI Management Effectiveness >> Compare RCPI ROA to its Competitors



More Return On Assets Ratios
RCPI's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
RCPI's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for RCPI's Competitors
Subscribers only: Roa for Rock Creek Pharmaceuticals's Suppliers
Subscribers only: Return On Assets for RCPI's Customers

You may also want to know
RCPI's Roi RCPI's Inventory Turnover Ratio RCPI's Growth Rates RCPI's Dividend Comparisons
RCPI's Profitability Ratios RCPI's Asset Turnover Ratio RCPI's Dividend Growth
RCPI's Roe RCPI's Valuation Ratios RCPI's Financial Strength Ratios RCPI's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2016, within Healthcare Sector ROA

Date modified: 2026-09-08T15:08:27+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.